Peanut Allergy Treatment Improves Quality of Life vs Peanut Avoidance
Individualized Methadone Restart Protocol May Improve Care, Maintain Safety
Awareness of “Food Is Medicine” Programs Is Low, But Interest Is High
Housing Assistance May Help Renters With Cancer Better Withstand Medical Financial Strain
Patients With HFpEF May Benefit From Accelerated Cardiac Pacing
Industry Payments Linked to Prescribing Patterns in MS Care
Rheumatoid Arthritis Linked to Elevated Risk of Degenerative Valvular Heart Disease
FDA Issues CRL for Bevacizumab Used for Wet AMD
Which US Counties Achieved the Best Health Care Performance?
Atopic Dermatitis Skin Clearance Maintained Over 3 Years With Lebrikizumab
Shingles Vaccine Generates Strong Immune Response in Patients With RA Receiving Upadacitinib
Risk of Corneal Edema Increased With Use of Glaucoma Drainage Devices
Global Gaps in Diabetes Technology, Insulin Linked to Poor Outcomes
Missed Opportunities for Salpingectomy Highlight Gaps in Ovarian Cancer Prevention
COVID-19 Vaccine Booster Receives Approval With Limits on Patient Access
Continuous Metabolic Syndrome Severity Score Linked With CKD Risk
Patients With Chronic Urticaria May Face Higher Risk of Metabolic Syndrome
Interhospital Transfers Occur Less Frequently for Uninsured Patients
Affirmative Action Repeal Decreases Minority Acceptance and Matriculation in Medical Schools
Brensocatib Approval Sparks New Questions in Bronchiectasis Research: James D. Chalmers, MBChB, PhD
Age, BTKi Use May Contribute to Cardiovascular Risk in CLL
Patient Engagement Can Help Drive More Comprehensive NSCLC Testing: Julia Rotow, MD
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
Identifying Signs of Presymptomatic MS, Radiologically Isolated Syndrome
Renal Denervation Shows Durable Blood Pressure Benefits in Key Trials: Deepak L. Bhatt, MD, MPH, MBA
Global Burden of MASH-Related Liver Cancer Rising Sharply Among Older Adults
Do SDOH Drive Survival Outcomes With Brexu-Cel in ALL?
AI Models Demonstrate Links Between IPF, Aging Processes
AP-1 as a Therapeutic Focus in CLL
Cutting-Edge and Basic Treatments Can Work in Tandem to Address NSCLC: Frank Weinberg, MD, PhD